Cullinan Therapeutics, Inc. CGEM Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Cullinan Therapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Cullinan Therapeutics, Inc. (CGEM) reported comprehensive income (loss), net of tax, attributable to parent of -$50.67M in Q4 2025.
- How has Cullinan Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Cullinan Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 3.9% year-over-year, from -$48.75M to -$50.67M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 3 years (2021 to 2025), Cullinan Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 48.8% compound annual growth rate (CAGR), from -$66.41M to -$218.73M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a more holistic view of the company's financial performance and changes in net assets beyond traditional accounting earnings. Investors use this to assess the total impact of all financial activities on the company's overall equity position.